Loss per Share

9 Months Ended

Oct. 27, 2024

The computation of basic and diluted loss per share was as follows:


	Three Months Ended				Nine Months Ended
(in thousands, except per share data)	October 27, 2024		October 29, 2023		October 27, 2024		October 29, 2023
Net loss attributable to common stockholders	$	(7,586)	$	(38,250)	$	(201,040)	$	(449,667)

Weighted-average shares outstanding–basic	75,319		64,216		68,385		64,048


Weighted-average shares outstanding–diluted	75,319		64,216		68,385		64,048

Loss per share:
Basic	$	(0.10)	$	(0.60)	$	(2.94)	$	(7.02)
Diluted	$	(0.10)	$	(0.60)	$	(2.94)	$	(7.02)

Anti-dilutive shares not included in the above calculations:
Share-based compensation	431		2,034		1,023		2,179

Warrants	8,573		8,573		8,573		8,573
Total anti-dilutive shares	9,004		10,607		9,596		10,752

Basic earnings or loss per share is computed by dividing income or loss available to common stockholders by the weighted-average number of shares of common stock outstanding during the reporting period. Diluted earnings or loss per share incorporates the incremental shares issuable, calculated using the treasury stock method, upon the assumed exercise of non-qualified stock options and the vesting of restricted stock units, market-condition restricted stock units and financial metric-based restricted stock units if certain conditions have been met, but excludes such incremental shares that would have an anti-dilutive effect. Due to the Company's net loss for the three and nine months ended October 27, 2024, all shares underlying stock options and restricted stock units are considered anti-dilutive.

Any dilutive effect of the Warrants (as defined in Note 9, Long-Term Debt) is calculated using the treasury-stock method. During the three and nine months ended October 27, 2024, the Warrants were excluded from diluted shares outstanding because the exercise price exceeded the average market price of the Company's common stock for the reporting periods and due to net loss in such reporting periods.